BAHAHHAHAHAHAHAHAHAHAHHA
HE SSAID IRANIAN PEOPLE
BAHAHAHAHAHAHAHAHAHAHAHAHA
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
Fabio Rocha Formiga,a,b,⁎ Roger Leblanc,c Juliana de Souza Rebouças,d Leonardo Paiva Farias,e Ronaldo Nascimento de Oliveira,f and Lindomar Penag
Author information Article notes Copyright and License information Disclaimer
This article has been cited by other articles in PMC.
Go to:
Abstract
Ivermectin is an FDA-approved broad-spectrum antiparasitic agent with demonstrated antiviral activity against a number of DNA and RNA viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite this promise, the antiviral activity of ivermectin has not been consistently proven in vivo. While ivermectin's activity against SARS-CoV-2 is currently under investigation in patients, insufficient emphasis has been placed on formulation challenges. Here, we discuss challenges surrounding the use of ivermectin in the context of coronavirus disease-19 (COVID-19) and how novel formulations employing micro- and nanotechnologies may address these concerns.